Skip Navigation
Skip to contents

대한신장학회


간행물 검색

현재 페이지 경로
  • HOME
  • 간행물
  • 간행물 검색
논문분류 춘계학술대회 초록집
제목 Polypharmacy and peripheral edema in korean elderly patients with chronic kidney disease (CKD)
저자 Jung Hwa Ryu
출판정보 2023; 2023(1):
키워드
초록 Objectives: Polypharmacy in elderly CKD patients is popular because of their comorbid conditions. Among the potential adverse drug reactions, drug-related peripheral edema is usually neglected in many multi-drug prescriptions. This study aimed to investigate the prevalence and risk factors for peripheral edema associated with polypharmacy in a CKD population. Methods: This prospective cross-sectional study was performed for CKD patients, aged over 65 years. We collected the demographic data including prescription medications; anti-hypertensive drugs, oral glucose-lowering drugs, antiplatelet drugs, analgesics, and neurologic medication. The grading of leg edema was determined by pit depth and recovery time from grades 0-4 (G0-G4). Results: The total of 372 CKD patients was enrolled in this study. The mean age was 72.7±11.3 years.The number of routinely prescribed medications was 1-3 in 37.1%, 4-6 in 36.2%, 7-9 in 19.6%, and over 10 in 7.1% of the patients. The mean eGFR was 54.2±12.5 ml/min/1.73m2. The number of prescriptions was higher in G4 edema group (15.4% in grade 1 vs. 28.2% in G4 edema group). Physical activity was lowest in higher edema group. The higher dose of dihydropyridine calcium-channel blocker (DHCCB) was prevalent in higher edema grade group (17.1% of amlodipine users in G0 vs. 44.2% in G4 group). Pregabalin and NSAID users were prevalent in higher edema-gradedgroup. Multivariate logistic regression analysis showed that a higher number of prescribed medications was an independent risk factor for peripheral edema; the HR of 4-6, 7-9, ≥10 of the medications was 2.062 (95%C.I.1.223-5.771), 2.226 (95%C.I.1.854-12.021), and 4.324 (95%C.I.3.102-12.174) compared to 1-3 of medication, respectively. Conclusions: Peripheral edema is frequent in CKD population and related with polypharmacy. Higher dose of DHCCB can be a risk factor for severe peripheral edema in CKD patients. Prescription cascade for diuretics should be concerned because it could be a result of drug-related edema.
원문(PDF) PDF 원문보기
위로가기